Hamilton Point Investment Advisors LLC Sells 2,993 Shares of Danaher Corporation $DHR

Key Points

• Hamilton Point Investment Advisors LLC reduced its stake in Danaher Corporation by 7.2%, selling 2,993 shares, which now accounts for approximately 1.3% of their investment portfolio, valued at $7,657,000.
• Wall Street analysts show a generally optimistic outlook for Danaher, with a consensus rating of "Moderate Buy" and an average target price of $244.60, despite some fluctuations in ratings from different firms.
• Danaher recently announced a quarterly dividend of $0.32 per share, resulting in an annualized dividend yield of 0.6%, set to be paid on October 31st.

Hamilton Point Investment Advisors LLC trimmed its stake in Danaher Corporation (NYSE:DHR - Free Report) by 7.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 38,698 shares of the conglomerate's stock after selling 2,993 shares during the period. Danaher comprises about 1.3% of Hamilton Point Investment Advisors LLC's investment portfolio, making the stock its 24th largest position. Hamilton Point Investment Advisors LLC's holdings in Danaher were worth $7,657,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently made changes to their positions in the company. GHP Investment Advisors Inc. lifted its stake in shares of Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after acquiring an additional 99 shares during the period. Sierra Ocean LLC lifted its stake in shares of Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after acquiring an additional 76 shares during the period. Red Tortoise LLC lifted its stake in shares of Danaher by 175.0% during the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate's stock valued at $30,000 after acquiring an additional 98 shares during the period. Smallwood Wealth Investment Management LLC acquired a new position in shares of Danaher during the first quarter valued at $31,000. Finally, Dunhill Financial LLC lifted its stake in shares of Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after acquiring an additional 67 shares during the period. Institutional investors own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of several research reports. Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Guggenheim restated a "buy" rating and set a $250.00 target price on shares of Danaher in a report on Wednesday, July 23rd. Rothschild Redb cut Danaher from a "strong-buy" rating to a "hold" rating in a report on Wednesday, October 8th. UBS Group decreased their price objective on shares of Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a report on Wednesday, July 23rd. Finally, Wells Fargo & Company reduced their price target on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research report on Wednesday, July 23rd. Seventeen research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $244.60.

Insider Activity at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the firm's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 11.20% of the company's stock.

Danaher Trading Up 1.4%

NYSE DHR opened at $205.36 on Tuesday. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The stock has a 50 day moving average of $200.82 and a 200-day moving average of $197.06. The company has a market cap of $147.05 billion, a PE ratio of 43.69, a PEG ratio of 2.88 and a beta of 0.77. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.41.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the previous year, the firm posted $1.72 EPS. Danaher's revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher's dividend payout ratio is presently 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.